Jefferies Maintains Buy for Precision BioSciences (DTIL) March 13, 2026
Jefferies maintained a Buy rating on Precision BioSciences, Inc. (DTIL) on March 13, 2026. The firm lowered its price target to $19 while saying the near-term setup remains attractive. The DTIL analyst rating note is the primary analyst action this week and gives investors a clear short-term signal. We review the Jefferies view, the price target change, and what this maintained Buy means for holders and potential buyers.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
